Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption

Nephrology Dialysis Transplantation

Volumn 12, Issue 5, 1997, Pages 1037-1039

  Faucher, C ^a,c   Albert, C ^a   Beaufils, H ^b   Jouanneau, C ^b   Dupouet, L ^a  

^a HÔPITAL DU BOCAGE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Hopitaux de Chartres   (France)

Author keywords

Ankylosing spondylitis; Hypercholesterolaemia; Hypertriglyceridaemia; LDL apheresis; Minimal change nephrotic syndrome; Priapism; Sulphasalazine

Indexed keywords

CHOLESTEROL; DEXTRAN SULFATE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANKYLOSING SPONDYLITIS; APHERESIS; ARTICLE; CASE REPORT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REMISSION;

ADSORPTION; ADULT; ANTIRHEUMATIC AGENTS; BLOOD COMPONENT REMOVAL; CHOLESTEROL; DEXTRAN SULFATE; HUMANS; LIPOPROTEINS, LDL; MALE; NEPHROTIC SYNDROME; SPONDYLITIS, ANKYLOSING; SULFASALAZINE; TRIGLYCERIDES;

EID: 0030955899     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.5.1037     Document Type: Article

References (11)

1. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985; 5: 613-622
2. Dwarakanath AD, Michael J, Allan RN. Sulphasalazine induced renal failure. Gut 1992; 33: 1006-1007
3. Barbour VM, Williams PF. Nephrotic syndrome associated with sulphasalazine. Br Med J 1988; 296: 1442
4. Moorhead JF, El-Nahas M, Chan MK, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 1982; 2: 1309-1311
5. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988; 33: 917-924
6. Klahr S, Harris K. Role of dietary lipids and renal eicosanoids on the progression of renal disease.Kidney Int 1989; 36: S27-S31
7. Hattori M, Ito K, Kawaguchi H, Tanaka T, Kubota R, Khono M. Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis. Pediatr Nephrol 1993; 7: 196-198
8. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 1994; 9: 257-264
9. Uauy R, Zwiener RJ, Philips MJ, Petruska ML, Bilheimer DW. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis. J Pediatr 1992; 120: 892-898
10. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 4: 375-383
11. Dantal J, Bigot E, Bogers W et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 7-14